Schering Sues Apotex Over Nasonex ANDA

Law360, New York (December 22, 2009, 7:14 PM EST) -- Merck & Co. Inc. unit Schering Corp. has accused Canadian drugmaker Apotex Inc. of infringing three patents related to Nasonex nasal spray by submitting an abbreviated new drug application for permission to market and distribute a generic version of the treatment.

In a complaint lodged Friday in the U.S. District Court for the District of New Jersey, Schering alleges that Apotex and its U.S. subsidiary Apotex USA have infringed the patents-in-suit by seeking the U.S. Food and Drug Administration's approval to develop a generic mometasone furoate...
To view the full article, register now.